Systems mapping of genes controlling chemotherapeutic drug efficiency for cancer stem cells

Weimiao Wu, Sisi Feng, Yaqun Wang, Ningtao Wang, Han Hao, Rongling Wu

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Cancer can be controlled effectively by using chemotherapeutic drugs to inhibit cancer stem cells, but there is considerable inter-patient variability regarding how these cells respond to drug intervention. Here, we describe a statistical framework for mapping genes that control tumor responses to chemotherapeutic drugs as well as the efficacy of treatments in arresting tumor growth. The framework integrates the mathematical aspects of the cancer stem cell hypothesis into genetic association studies, equipped with a capacity to quantify the magnitude and pattern of genetic effects on the kinetic decline of cancer stem cells in response to therapy. By quantifying how specific genes and their interactions govern drug response, the model provides essential information to tailor personalized drugs for individual patients.

Original languageEnglish (US)
Pages (from-to)1125-1130
Number of pages6
JournalDrug Discovery Today
Volume19
Issue number8
DOIs
StatePublished - Jan 1 2014

Fingerprint

Neoplastic Stem Cells
Chromosome Mapping
Pharmaceutical Preparations
Neoplasms
Genetic Association Studies
Drug Interactions
Growth
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

Wu, Weimiao ; Feng, Sisi ; Wang, Yaqun ; Wang, Ningtao ; Hao, Han ; Wu, Rongling. / Systems mapping of genes controlling chemotherapeutic drug efficiency for cancer stem cells. In: Drug Discovery Today. 2014 ; Vol. 19, No. 8. pp. 1125-1130.
@article{10d4e396da0d4ac89eece5189b155f0a,
title = "Systems mapping of genes controlling chemotherapeutic drug efficiency for cancer stem cells",
abstract = "Cancer can be controlled effectively by using chemotherapeutic drugs to inhibit cancer stem cells, but there is considerable inter-patient variability regarding how these cells respond to drug intervention. Here, we describe a statistical framework for mapping genes that control tumor responses to chemotherapeutic drugs as well as the efficacy of treatments in arresting tumor growth. The framework integrates the mathematical aspects of the cancer stem cell hypothesis into genetic association studies, equipped with a capacity to quantify the magnitude and pattern of genetic effects on the kinetic decline of cancer stem cells in response to therapy. By quantifying how specific genes and their interactions govern drug response, the model provides essential information to tailor personalized drugs for individual patients.",
author = "Weimiao Wu and Sisi Feng and Yaqun Wang and Ningtao Wang and Han Hao and Rongling Wu",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.drudis.2013.12.010",
language = "English (US)",
volume = "19",
pages = "1125--1130",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "8",

}

Systems mapping of genes controlling chemotherapeutic drug efficiency for cancer stem cells. / Wu, Weimiao; Feng, Sisi; Wang, Yaqun; Wang, Ningtao; Hao, Han; Wu, Rongling.

In: Drug Discovery Today, Vol. 19, No. 8, 01.01.2014, p. 1125-1130.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Systems mapping of genes controlling chemotherapeutic drug efficiency for cancer stem cells

AU - Wu, Weimiao

AU - Feng, Sisi

AU - Wang, Yaqun

AU - Wang, Ningtao

AU - Hao, Han

AU - Wu, Rongling

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Cancer can be controlled effectively by using chemotherapeutic drugs to inhibit cancer stem cells, but there is considerable inter-patient variability regarding how these cells respond to drug intervention. Here, we describe a statistical framework for mapping genes that control tumor responses to chemotherapeutic drugs as well as the efficacy of treatments in arresting tumor growth. The framework integrates the mathematical aspects of the cancer stem cell hypothesis into genetic association studies, equipped with a capacity to quantify the magnitude and pattern of genetic effects on the kinetic decline of cancer stem cells in response to therapy. By quantifying how specific genes and their interactions govern drug response, the model provides essential information to tailor personalized drugs for individual patients.

AB - Cancer can be controlled effectively by using chemotherapeutic drugs to inhibit cancer stem cells, but there is considerable inter-patient variability regarding how these cells respond to drug intervention. Here, we describe a statistical framework for mapping genes that control tumor responses to chemotherapeutic drugs as well as the efficacy of treatments in arresting tumor growth. The framework integrates the mathematical aspects of the cancer stem cell hypothesis into genetic association studies, equipped with a capacity to quantify the magnitude and pattern of genetic effects on the kinetic decline of cancer stem cells in response to therapy. By quantifying how specific genes and their interactions govern drug response, the model provides essential information to tailor personalized drugs for individual patients.

UR - http://www.scopus.com/inward/record.url?scp=84906322173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906322173&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2013.12.010

DO - 10.1016/j.drudis.2013.12.010

M3 - Review article

C2 - 24397982

AN - SCOPUS:84906322173

VL - 19

SP - 1125

EP - 1130

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 8

ER -